Medical News

Association between Gut Microbiota and Irritable Bowel Syndrome

This systematic review highlighted the heterogeneity of the microbiota in patients with irritable bowel syndrome (IBS). The results revealed that...

08 Jul, 2019

Email this page
Once daily Vs Multiple-daily Amoxicillin in Children with GAS Pharyngitis

Recently researchers compared the effects of once-daily and multiple-daily administrations of oral amoxicillin on bacterial load in throat swabs...

08 Jul, 2019

Email this page
NLR, A Valuable Indicator of SSI in Patients with Posterior Lumbar Spinal Surgery

The neutrophil/lymphocyte ratio (NLR) is a significant indicator of infection or inflammation. It is faster and superior to leukocytes and C-...

04 Jul, 2019

Email this page
Infants Hospitalized for Bronchiolitis have a High Risk of Rehospitalization for Respiratory Problems till Age Five Years

One in five infants hospitalized for bronchiolitis will have a subsequent hospitalization for respiratory problem by age 5 years, stated a recent...

02 Jul, 2019

Email this page

Our Publications

Clarithromycin: An Emerging Treatment Recourse in Lower Respiratory Tract Infections

Parenteral macrolide therapy is needed for patients with moderate to severe CAP/AECB. This booklet gives an overview of the efficacy and safety of...

Approach to Hepatitis B in Pregnancy

Chronic hepatitis B virus (HBV) infection in pregnancy is an important global health problem. Over 50% of the estimated 240–350 million chronic...

HCV Management Series: Management of Treatment-naïve and Treatment-experienced HCV Patients

Treatment for hepatitis C is rapidly evolving from injectable interferons to the revolutionizing all oral direct-acting antivirals. The advent of...

Isoniazid + Pyridoxine + Sulfamethoxazole + Trimethoprim - Fixed Dose Combination: Concept Document

Tuberculosis is the most common opportunistic infections among people living with HIV. Isoniazid preventive therapy is effective strategy to reduce...

Slide Library

4 R’s of Antibiotcs

Antibiotics are life-saving drugs, but unlike drugs used in other therapeutic areas, the future utility of many antibiotics is threatened by the...

Email this page

This presentation includes information pertaining to the molecule Luliconazole, which is a novel topical imidazole antifungal agent used for the...

Email this page
HIV - HCV Coinfection

This slide set covers the epidemiology, disease progression and management of HIV-HCV coinfection in the era of directly acting antivirals available...

Email this page
Basics of Hepatitis C

Hepatitis C is a viral infection that affects liver of 170 million people across the globe. It is one of the largest causes of liver cirrhosis and...

Email this page

Key Trials

Ibuprofen for Initial Symptomatic Treatment of Uncomplicated UTI

The present study analyses the rate of antibiotic prescriptions with Ibuprofen treatment for symptomatic treatment of uncomplicated UTI compared to...

Efficacy and Safety of Oral Ciprofloxacin in Management of External Bacterial Otitis

The present study evaluated the efficacy and safety of oral ciprofloxacin in the management of external bacterial otitis. The 10-day treatment with...

PROMISE Study: Moxifloxacin, Clinically and Bacteriologically Non-inferior to Ertapenem in Treatment of cIAIs

PROMISE is the largest study of antimicrobials performed in complicated intra-abdominal infections (cIAIs) patients. The study compared the clinical...

OSTRICH: A Short Course of Oral Steroid Treatment not Beneficial over Placebo for Treating Otitis Media with Effusion in Children

The OSTRICH trial found no benefits of short course of oral steroids over placebo for treating persistent otitis media with effusion in children.  


Is there a place for inhaled antibiotic therapy in managing patients with NON-CF bronchiectasis?
0% (0 votes)
0% (0 votes)
Total votes: 0